Logo image of EBS

EMERGENT BIOSOLUTIONS INC (EBS) Stock Analyst Ratings

USA - NYSE:EBS - US29089Q1058 - Common Stock

9.74 USD
+0.08 (+0.83%)
Last: 10/24/2025, 8:20:27 PM
9.7348 USD
-0.01 (-0.05%)
After Hours: 10/24/2025, 8:20:27 PM
Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to EBS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 13.77. This target is 41.38% above the current price.
EBS was analyzed by 7 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about EBS.
In the previous month the buy percentage consensus was at a similar level.
EBS was analyzed by 7 analysts. More opinions would make the average more meaningful.
EBS Historical Analyst RatingsEBS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -106 -96 -86 -76 -66 -56 -46 -36 -26 -16 -6 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 9.7412.1213.7713.7715.75 - 24.44% 41.38% 41.38% 61.70%
EBS Current Analyst RatingEBS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-09-03 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-01 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-21 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-04 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-21 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-30 HC Wainwright & Co. Initiate Buy
2024-11-07 Benchmark Maintains Buy -> Buy
2024-09-13 Rodman & Renshaw Reiterate Buy -> Buy
2024-08-22 Rodman & Renshaw Initiate Buy
2024-08-16 Benchmark Reiterate Buy -> Buy
2024-08-09 Benchmark Reiterate Buy -> Buy
2024-07-03 Benchmark Reiterate Buy -> Buy
2024-07-02 Benchmark Reiterate Buy -> Buy
2024-06-24 Benchmark Reiterate Buy -> Buy
2024-06-21 Benchmark Reiterate Buy -> Buy
2024-06-20 Benchmark Maintains Buy -> Buy
2024-04-11 Benchmark Reiterate Buy -> Buy
2024-03-07 Benchmark Upgrade Hold -> Buy
2023-11-20 JP Morgan Reiterate Underweight
2023-08-29 Benchmark Downgrade Buy -> Hold
2023-05-31 Benchmark Reiterate Buy -> Buy
2023-05-19 Benchmark Reiterate Buy -> Buy
2023-04-10 Benchmark Upgrade Hold -> Buy
2023-03-17 JP Morgan Downgrade Neutral -> Underweight
2022-11-10 Benchmark Downgrade Buy -> Hold
2022-11-09 Chardan Capital Maintains Buy
2022-09-12 Cowen & Co. Maintains Market Perform
2022-05-04 Wells Fargo Maintains Equal-Weight
2022-04-29 Chardan Capital Maintains Buy

EMERGENT BIOSOLUTIONS INC / EBS FAQ

What do analysts expect the price target to be for EMERGENT BIOSOLUTIONS INC (EBS)?

7 analysts have analysed EBS and the average price target is 13.77 USD. This implies a price increase of 41.38% is expected in the next year compared to the current price of 9.74.


What is the consensus rating for EBS stock?

The consensus rating for EMERGENT BIOSOLUTIONS INC (EBS) is 74.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.